Supreme Court maintains access to abortion pill mifepristone by mail
The Supreme Court has ruled to keep the abortion pill mifepristone available through telehealth and mail. This decision comes amid ongoing legal challenges regarding the pill's accessibility. (sources: npr, nbcnews, ap, thehill, 19thnews)
The Supreme Court has decided that patients can continue to receive mifepristone by mail without needing an in-person appointment. This ruling follows a previous decision by the 5th U.S. Circuit Court of Appeals that threatened access to the medication.
- The Supreme Court ruled to preserve access to mifepristone by mail and telehealth.
- This decision allows patients to obtain the abortion pill without an in-person visit.
- The ruling comes while a lawsuit regarding the pill's availability is still ongoing.
Why it matters
This ruling affects the accessibility of a widely used abortion medication during ongoing legal disputes.
↓ Why this is on ModernAction
4 bills on this issue are moving right now — and the most active one is Stop Comstock Act.
H.R.2029 · 119th Congress
Stop Comstock Act
Where do you stand on this bill?
Takes about 60 seconds
About this bill
What H.R.2029 actually does
This story is about Supreme Court maintains access to abortion pill mifepristone by mail. This bill would Amend federal criminal/related provisions historically cited in arguments about mailing abortion-related items.
If passed, it would:
- Amend federal criminal/related provisions historically cited in arguments about mailing abortion-related items • Reduce the risk that federal Comstock provisions are used as a nationwide mail-ban lever.
3 other bills moving on this issue
Take action on any of them individually.
This story is about Supreme Court maintains access to abortion pill mifepristone by mail. This bill would This bill is another direct response to the same FDA/REMS “guardrails” fight that drives whether mifepristone would be accessed through telehe.
If passed, it would
- Constrain federal policy flexibility around medication abortion regulation (including mifepristone REMS changes • Add statutory conditions that would make mail/telehealth access harder to maintain or expand.
This story is about Supreme Court maintains access to abortion pill mifepristone by mail. This bill would The Supreme Court news is about continued telehealth/mail access; this bill would nullify the FDA’s January 2023 mifepristone REMS changes t.
If passed, it would
- Undo the FDA’s January 2023 REMS modifications for mifepristone • Block similar FDA changes in the future (as described in the bill summary on Congress.gov.
This story is about Supreme Court maintains access to abortion pill mifepristone by mail. This bill would require HHS/FDA to replace the current mifepristone REMS with one identical to the June 2011 REMS.
If passed, it would
- Require HHS/FDA to replace the current mifepristone REMS with one identical to the June 2011 REMS • Add liability and import/mailing-related restrictions described in the introduced text.
Top coverage · 7 sources